








This 40:1 myo-to-D-chiro-inositol blend fits women looking for ovulatory and menstrual cycle support, those working on insulin sensitivity, or anyone trying to conceive with sporadic ovulation. People focused on metabolic health and triglyceride support often do well. If your cycles are already regular and your metabolic labs are solid, inositol is less likely to change much.
Myo-inositol acts as a second messenger for insulin, helping carry the insulin signal inside cells so glucose moves out of the bloodstream more efficiently. Adding a small amount of D-chiro-inositol keeps the 40:1 ratio the ovary prefers, which supports normal egg development and ovulation. As insulin sensitivity improves, ovarian androgen output tends to balance, which is why cycles often become more regular. Expect metabolic markers like fasting insulin and triglycerides to follow the clinical changes.
Theralogix Ovasitol delivers 2,000 mg myo-inositol plus 50 mg D-chiro-inositol per scoop. Taken twice daily it reaches the 4 g/day 40:1 ratio supported by published cycle and metabolic research. Mix in any non-carbonated drink, morning and evening, with or without food. Consistency matters: most see cycle changes within 4 to 12 weeks, with metabolic markers shifting over 8 to 16 weeks. If conception support is the goal, plan on 3 to 6 months of steady use before judging.
If you take prescription medications, are pregnant or breastfeeding, or are working with a clinician on a specific protocol, talk to them before starting and review the warnings below.
Most women who respond see cycle regularity improve within 4 to 12 weeks. Ovulation quality and conception outcomes often need 3 to 6 months. Staying consistent with twice-daily dosing matters.
A 40:1 ratio of myo-inositol to D-chiro-inositol matches the ovary's natural balance and has the strongest research support for ovulation and insulin signaling.
Yes. They are often combined. Monitor for low blood sugar if you also use insulin or sulfonylureas. Track fasting glucose and fasting insulin with your clinician.
Weight change is usually modest. Inositol's main effect is steadier insulin signaling, which can reduce cravings and improve metabolic markers like triglycerides over time.
Often continued into early pregnancy under OB guidance. Discuss individually with your obstetrician before continuing.
Most tolerate it well. Some notice bloating, gas, or mild dizziness at first. Splitting the dose twice daily and taking with food usually solves it; reduce and re-titrate if needed.
Track fasting insulin, fasting glucose, and triglycerides. If conception is a goal, cycle tracking or ovulation testing provides faster feedback than labs alone.
Yes, inositol can support insulin signaling in men. Men typically use myo-inositol 2 to 4 g/day under guidance.